BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 7506570)

  • 1. Diagnosis of paroxysmal nocturnal haemoglobinuria by phenotypic analysis of erythrocytes using two-colour flow cytometry with monoclonal antibodies to DAF and CD59/MACIF.
    Shichishima T; Terasawa T; Saitoh Y; Hashimoto C; Ohto H; Maruyama Y
    Br J Haematol; 1993 Oct; 85(2):378-86. PubMed ID: 7506570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogenous expression of decay accelerating factor and CD59/membrane attack complex inhibition factor on paroxysmal nocturnal haemoglobinuria (PNH) erythrocytes.
    Shichishima T; Terasawa T; Hashimoto C; Ohto H; Uchida T; Maruyama Y
    Br J Haematol; 1991 Aug; 78(4):545-50. PubMed ID: 1716957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The erythrocytes in paroxysmal nocturnal haemoglobinuria of intermediate sensitivity to complement lysis.
    Rosse WF; Hoffman S; Campbell M; Borowitz M; Moore JO; Parker CJ
    Br J Haematol; 1991 Sep; 79(1):99-107. PubMed ID: 1716964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discordant and heterogeneous expression of GPI-anchored membrane proteins on leukemic cells in a patient with paroxysmal nocturnal hemoglobinuria.
    Shichishima T; Terasawa T; Hashimoto C; Ohto H; Takahashi M; Shibata A; Maruyama Y
    Blood; 1993 Apr; 81(7):1855-62. PubMed ID: 7681703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simplified assay for the specific diagnosis of paroxysmal nocturnal hemoglobinuria: detection of DAF(CD55)- and HRF20(CD59)- erythrocytes in microtyping cards.
    Nilsson B; Hagström U; Englund A; Säfwenberg J
    Vox Sang; 1993; 64(1):43-6. PubMed ID: 7680511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longer in vivo survival of CD59- and decay-accelerating factor-almost normal positive and partly positive erythrocytes in paroxysmal nocturnal hemoglobinuria as compared with negative erythrocytes: a demonstration by differential centrifugation and flow cytometry.
    Fujioka S; Yamada T
    Blood; 1992 Apr; 79(7):1842-5. PubMed ID: 1373090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decay-accelerating factor and CD59 expression in peripheral blood cells in aplastic anaemia and report of a case of paroxysmal nocturnal haemoglobinuria secondary to aplastic anaemia.
    Fujioka S; Yamada T
    Br J Haematol; 1993 Apr; 83(4):660-2. PubMed ID: 7686037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New monoclonal antibodies in CD59: use for the analysis of peripheral blood cells from paroxysmal nocturnal haemoglobinuria (PNH) patients and for the quantitation of CD59 on normal and decay accelerating factor (DAF)-deficient erythrocytes.
    Fletcher A; Bryant JA; Gardner B; Judson PA; Spring FA; Parsons SF; Mallinson G; Anstee DJ
    Immunology; 1992 Mar; 75(3):507-12. PubMed ID: 1374058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markedly high population of affected reticulocytes negative for decay-accelerating factor and CD59 in paroxysmal nocturnal hemoglobinuria.
    Iwamoto N; Kawaguchi T; Nagakura S; Hidaka M; Horikawa K; Kagimoto T; Takatsuki K; Nakakuma H
    Blood; 1995 Apr; 85(8):2228-32. PubMed ID: 7536494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two distinct patterns of glycosylphosphatidylinositol (GPI) linked protein deficiency in the red cells of patients with paroxysmal nocturnal haemoglobinuria.
    Hillmen P; Hows JM; Luzzatto L
    Br J Haematol; 1992 Mar; 80(3):399-405. PubMed ID: 1374629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paroxysmal nocturnal hemoglobinuria with myelofibrosis: progression to acute myeloblastic leukemia.
    Nakahata J; Takahashi M; Fuse I; Nakamori Y; Nomoto N; Saitoh H; Tatewaki W; Imanari A; Takeshige T; Koike T
    Leuk Lymphoma; 1993 Dec; 12(1-2):137-42. PubMed ID: 7512853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rapid diagnosis of paroxysmal nocturnal hemoglobinuria by gel test agglutination].
    Navenot JM; Bernard D; Petit-Frioux Y; Loirat MJ; Guimbretière J; Muller JY; Blanchard D
    Rev Fr Transfus Hemobiol; 1993 Apr; 36(2):135-47. PubMed ID: 7684909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implication of membrane factors other than DAF and CD59 in complement-mediated lysis of paroxysmal nocturnal hemoglobinuria erythrocytes.
    Hatanaka M; Inai S; Matsumoto M; Miyagawa S; Masaoka T; Kanamaru A; Kawakita M; Yonemura Y; Sugita Y; Seya T
    Clin Immunol Immunopathol; 1993 Oct; 69(1):52-9. PubMed ID: 7691453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria.
    Hall SE; Rosse WF
    Blood; 1996 Jun; 87(12):5332-40. PubMed ID: 8652849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of decay-accelerating factor and CD59 in lymphocyte subsets of healthy individuals and paroxysmal nocturnal hemoglobinuria patients.
    Nagakura S; Nakakuma H; Horikawa K; Hidaka M; Kagimoto T; Kawakita M; Tomita M; Takatsuki K
    Am J Hematol; 1993 May; 43(1):14-8. PubMed ID: 7686331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A standardized flow cytometric method for screening paroxysmal nocturnal haemoglobinuria (PNH) measuring CD55 and CD59 expression on erythrocytes and granulocytes.
    Oelschlaegel U; Besson I; Arnoulet C; Sainty D; Nowak R; Naumann R; Bux Y; Ehninger G
    Clin Lab Haematol; 2001 Apr; 23(2):81-90. PubMed ID: 11488846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Paroxysmal nocturnal hemoglobinuria (PNH) deficiency of major complement-regulatory membrane proteins on erythrocytes].
    Ninomiya H; Kobayashi T; Abe T
    Rinsho Ketsueki; 1991 Jun; 32(6):612-7. PubMed ID: 1716325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric analysis of glycosylphosphatidyl-inositol-anchored proteins to assess paroxysmal nocturnal hemoglobinuria clone size.
    Piedras J; López-Karpovitch X
    Cytometry; 2000 Aug; 42(4):234-8. PubMed ID: 10934342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease-modified erythrocytes: CD55 and CD59 deficient PNH-like cells.
    Yuan FF; Bryant JA; Fletcher A
    Immunol Cell Biol; 1995 Feb; 73(1):66-72. PubMed ID: 7539403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometry and immunoblotting analysis of monoclonal antibodies directed to complement regulatory proteins.
    Blanchard D; Navenot JM; Petit-Le Roux Y; Willem C; Loirat MJ
    Transfus Clin Biol; 1997; 4(1):131-4. PubMed ID: 9095519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.